Navigation Links
WuXi PharmaTech Presents 2010 Life Science and Chemistry Awards
Date:12/13/2010

SHANGHAI, Dec. 13, 2010 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company, with operations in China and the United States, today announced the winners of its fourth annual Life Science and Chemistry Awards at a ceremony held at the China World Hotel in Beijing.

Awards were given in medicinal chemistry and natural products. Junqi Yan, Vice Chairwoman of the Standing Committee of the 11th National People's Congress of China, Chairwoman of the Central Committee of the China Association for Promoting Democracy, and Dean of the Central Institute of Socialism, and Huaixi Zhang, Vice Chairman of the 10th Chinese People's Political Consultative Conference, presented the awards. They congratulated the winners, encouraging them to continue making important contributions to China's scientific development.

Mrs. Yan served as honorary Chairwoman of the selection panel, which was comprised of nine scholars with extensive expertise in the life science industry:

  • Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech
  • Dr. Shuhui Chen, Chief Scientific Officer of WuXi PharmaTech
  • Dr. Chengde Wu, Vice President of Medicinal Chemistry of WuXi PharmaTech
  • Dr. Tao Guo, Vice President of Medicinal Chemistry of WuXi PharmaTech
  • Dr. Kaixian Chen, President of Shanghai University of Traditional Chinese Medicine and Academician of the Chinese Academy of Sciences
  • Dr. Lihe Zhang, Professor at the School of Pharmaceutical Sciences of Beijing University
  • Dr. Guoqiang Lin, Professor at the Shanghai Institute of Organic Chemistry and Academician of the Chinese Academy of Sciences
  • Dr. Xinsheng Yao, Professor at Jinan University and Academician of the Chinese Academy of Engineering
  • Dr. Naizheng Huang, Professor at the Chine
    '/>"/>

  • SOURCE WuXi PharmaTech (Cayman) Inc
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting
    2. WuXi PharmaTech Announces Third-Quarter 2010 Results
    3. WuXi PharmaTech Awarded GLP Certificate from SFDA for Suzhou Toxicology Facility
    4. WuXi PharmaTech Schedules Third-Quarter 2010 Earnings Conference Call
    5. Professor Steven V. Ley Speaks at WuXi PharmaTech
    6. WuXi PharmaTech Awarded GLP Certificate from OECD for Suzhou Toxicology Facility
    7. WuXi PharmaTech Announces Second-Quarter 2010 Results
    8. WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
    9. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
    10. WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
    11. WuXi PharmaTech Announces First-Quarter 2010 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/1/2015)... September 1, 2015 BerGenBio AS ... announces that it has appointed Hilde Furberg ... to its Board of Directors, effective immediately. ... experience in pharma and biotech and is currently Senior ... company. Previously her role was Vice President and General ...
    (Date:9/1/2015)... 1, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... that its affiliate has entered into a collaboration ... an exclusive license to develop and commercialize brodalumab. ... monoclonal antibody in development for patients with moderate-to-severe ... Valeant will hold the exclusive rights to develop ...
    (Date:8/31/2015)... PHOENIX , Aug. 31, 2015  DICOM ... announced today that it was recognized as a ... Radiology software.  The awards are sponsored ... and related professionals in the medical imaging industry.  ... for radiology professionals to acknowledge the contributions of ...
    Breaking Medicine Technology:BerGenBio Appoints Non-Executive Directors 2Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2
    ... 2012   Syndax Pharmaceuticals, Inc. and Ventana Medical ... an agreement to develop a companion diagnostic assay to ... treatment with erlotinib and Syndax,s proprietary lead molecule entinostat.  ... Ventana, a world leader and innovator of tissue-based diagnostic ...
    ... (Nasdaq: VRNM ), a leading industrial biotechnology ... enzymes, today announced the introduction of VEREFLOW™ alpha-amylase, a ... drilling operations.  This high performance enzyme effectively removes filter ... on the face of the wellbore, the hole drilled ...
    Cached Medicine Technology:Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat 2Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat 3Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat 4Verenium Launches Second Enzyme Product for Oilfield Services 2Verenium Launches Second Enzyme Product for Oilfield Services 3
    (Date:9/1/2015)... NV (PRWEB) , ... September 01, 2015 , ... ... or Self-Directed Care is, how to access caregivers and what to look for ... valuable and pertinent information. , Founded in 2006 in Canoga Park, CA by ...
    (Date:9/1/2015)... ... September 01, 2015 , ... ... it has established the MAP Recovery Network, the Premier Outcomes-Driven Provider Network. ... This rapidly-growing alliance is dedicated to the provision of quality addiction treatment ...
    (Date:9/1/2015)... ... September 01, 2015 , ... The integration ... patients directly from Practice Perfect to FOTO enabling cost and time savings, reducing ... , Steven Presement, President of Practice Perfect, stated "FOTO is a natural extension ...
    (Date:9/1/2015)... ... ... Elizabeth Callahan, MD, founder and medical director of SkinSmart Dermatology® , ... filler treatment for volume loss in the hands. RADIESSE provides an immediate volumizing effect ... delivering smooth, natural-looking results that can last up to one year in most patients. ...
    (Date:9/1/2015)... ... ... Routines… every family has them. Whether it’s a morning routine, meal time routine or ... too. Here are three reasons why routines can be beneficial for a child: , ... is implemented into a child’s schedule, they are able to anticipate what will happen ...
    Breaking Medicine News(10 mins):Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2Health News:MAP Health Management Launches the MAP Recovery Network 2Health News:FOTO Announces New Integration Partnership with Practice Perfect 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:Back into the Swing of Things: How Family Routines Benefit Children 2
    ... the 66th Annual Meeting of the American Academy ... ... AGI Dermatics presented,clinical research that indicates the 8-oxo-guanine DNA glycosylase (OGG1),encapsulated ... DNA repair, reducing MMP-1 secretion and increasing,collagen production in UV irradiated ...
    ... Uroplasty, Inc. (Amex:,UPI), a medical device company ... for the treatment of voiding dysfunction,announced today ... minimally invasive nerve stimulation device, designed for,office-based ... be,featured in three presentations at the Society ...
    ... Feb. 11 /PRNewswire-FirstCall/ - Neurochem Inc. (NASDAQ:,NRMX; TSX: ... 2008, Dr.,Francesco Bellini, Neurochem,s Chairman, President and Chief ... of the new,nutraceutical business, will present Neurochem,s strategy ... be held at the Waldorf-Astoria, in New York,(NY). ...
    ... bedside manner as better informed patients make ever-increasing demands ... in clinical decisions that directly affect their care. ... Related Research, Dr. J. Bohannon Mason of the Orthocarolina ... at the changes in society, the population and technology ...
    ... incidence of malignancy, so women with this condition can ... to a new study by a team of researchers ... A fibroadenoma is a benign growth of the breast ... usually associated with breast cancer, and are often diagnosed ...
    ... 2008 Researchers at Pulmonary Associates today announced ... for Emphysema) Trial, an international, multi-center clinical trial ... a new, minimally invasive option for those suffering ... airway bypass, a catheter-based bronchoscopic procedure designed to ...
    Cached Medicine News:Health News:AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair 2Health News:AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair 3Health News:Studies on Urgent(R) PC to be Presented at the 2008 Society of Urologic Nurses and Associates Annual Symposium 2Health News:Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live 2Health News:Doctor who? Are patients making clinical decisions? 2Health News:Study finds patients with complex fibroadenomas can avoid surgery 2Health News:Researchers at Pulmonary Associates to study airway bypass procedure for severe emphysema 2
    FLEXILOG spare part....
    Complete calibration kits are available for both pH and manometry systems....
    Flexilog custom medical carts are configured to suite the requirements of FLEXILOG motility system users. With locking wheels and storage drawers, our carts are suitable for any care provider in any ...
    ... kit for convenient pH catheter calibration., ,pH ... any procedure. The Alpine Calibration kit contains ... water for your convenience. Simply cut the ... catheters to soak. No measuring or pouring! ...
    Medicine Products: